ÂÜÀòÂÒÂ×

Alexis Borisy is a prominent figure in the biotechnology sector with extensive experience in leadership and entrepreneurship. As Co-Founder and Chairman of Curie.Bio and IDRx, along with serving as Founder and Executive Chairman of EQRx, Borisy demonstrates a strong commitment to innovation in healthcare. Additional roles include Board Member at Nextech Invest, Chairman of the Board at Tango Therapeutics, and Co-Founder and Chairman at Relay Therapeutics. Borisy has also held influential positions with Blueprint Medicines and REVOLUTION Medicines, contributing as a Founding Investor and Board Member. With a solid educational background that includes a Master's degree in Chemistry and Chemical Biology from Harvard University and a Bachelor's degree in Chemistry from the University of Chicago, Borisy's impact on the industry is significant and ongoing.